[BUSINESS]■ STORY TIMELINE
BOEHRINGER INGELHEIM TAPS OWKIN AI FOR DRUG DISCOVERY
Boehringer Ingelheim has signed a deal to use Owkin's artificial intelligence model for discovering oncology and immunology drugs, joining AstraZeneca and Sanofi as major pharma clients of the AI platform.
Bloomberg Tech+0m
Boehringer Ingelheim GmbH agreed to use Owkin’s artificial-intelligence model to help discover new oncology and immunolo…